Pomalidomide for Chronic Graft-versus-Host Disease
NCT01688466
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
34
Enrollment
NIH
Sponsor class
Conditions
Graft vs Host Disease
Graft-Versus-Host Disease
Interventions
DRUG:
Pomalidomide
Sponsor
National Cancer Institute (NCI)